Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 4,665
Out of 4,667 analysts
21
Total ratings
7.14%
Success rate
-48.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNOX Bionomics | Maintains: Buy | $10 → $17 | $0.28 | +5,921.96% | 3 | Mar 9, 2023 | |
| ATAI Atai Life Sciences | Initiates: Buy | $18 | $1.59 | +1,032.08% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $16.27 | +4.49% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $4.66 | +629.61% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $94.60 | +0.42% | 2 | Nov 1, 2022 | |
| SAGE Sage Therapeutics | Initiates: Hold | $41 | $4.91 | +735.03% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $1.20 | +66.67% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $33 | $0.64 | +5,037.79% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $3.01 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $4.76 | +572.27% | 4 | Dec 16, 2020 |
Bionomics
Mar 9, 2023
Maintains: Buy
Price Target: $10 → $17
Current: $0.28
Upside: +5,921.96%
Atai Life Sciences
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $1.59
Upside: +1,032.08%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $16.27
Upside: +4.49%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $4.66
Upside: +629.61%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $94.60
Upside: +0.42%
Sage Therapeutics
Nov 1, 2022
Initiates: Hold
Price Target: $41
Current: $4.91
Upside: +735.03%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $1.20
Upside: +66.67%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $33
Current: $0.64
Upside: +5,037.79%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $3.01
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $4.76
Upside: +572.27%